Try our beta test site
1 study found for:    22863660 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric dengue serotype 1, 2, 3, and 4;   Biological: Pneumococcal polysaccharide vaccine

Study has passed its completion date and status has not been verified in more than two years.